PUBLICATIONS

Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance

Perlman BS, Burget NG, Zhou Y, Schwartz GW, Petrovic J, Modrusan Z, Faryabi RB

Nature Communications

2024

Oncogenic transcription factors instruct promoter-enhancer hubs in individual triple negative breast cancer cells

Zhao J, Zhou Y, Tzelepis I, Burget NG, Shi J, Faryabi RB

Science Advances

2024

AnnoSpat annotates cell types and quantifies cellular arrangements from spatial proteomics

Mongia A, Zohora FT, Burget NG, Zhou Y, Saunders DC, Wang YJ, Brissova M, Powers AC, Kaestner KH, Vahedi G, Naji A, Schwartz GW, Faryabi RB

Nature Communications

2024

Modeling type 1 diabetes progression using machine learning and single-cell transcriptomic measurements in human islets

Patil AR, Schug J, Liu C, Lahori D, Descamps HC; Human Pancreas Analysis Consortium; Naji A, Kaestner KH, Faryabi RB, Vahedi

Cell Reports Medicine

2024

Intrinsically disordered domain of transcription factor TCF-1 is required for T cell developmental fidelity

Goldman N, Chandra A, Johnson I, Sullivan MA, Patil AR, Vanderbeck A, Jay A, Zhou Y, Ferrari EK, Mayne L, Aguilan J, Xue HH, Faryabi RB, John Wherry E, Sidoli S, Maillard I, Vahedi G

Nature Immunology

2023